ASXNotice of AGM and Meeting Materials
other announcement
NXN
Nexsen
Pharmaceuticals, Biotechnology & Life Sciences
Short position
short percentage0.02%
reported shorts21.8K
shares on issue92.766M
Nexsen (ASX:NXN) has 0.02% of its shares on issue reported as short positions as of 6 July 2026, or about 21,838 shares. NXN is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Nexsen (NXN) News
Latest articles and price-sensitive announcements with AI sentiment classification.
Professor Shekhar Kumta appointed Executive Director
other announcement
Small CapsNexsen Enters into Molecular GBS Diagnostic Joint Venture with FlashDx Shenzhen
Nexsen to form a 50:50 GBS diagnostic JV with FlashDx Shenzhen, targeting FDA 510(k) and EU IVDR clearance and APAC market entry.
Proposed FlashDx joint venture builds on CE-marked GBS test
other announcement
Clear pathway defined to optimise StrepSure
other announcement
Director Interest Notices re Performance Rights
director_dealing announcement
Notification regarding unquoted securities - NXN
other announcement
Corporate Governance Statement and Appendix 4G
other announcement
Google NewsWe're Not Very Worried About Nexsen's (ASX:NXN) Cash Burn Rate - simplywall.st
We're Not Very Worried About Nexsen's (ASX:NXN) Cash Burn Rate simplywall.st
Nexsen (ASX:NXN) Small-Cap Volatility Highlights Importance of Corporate Developments - Kalkine
Nexsen (ASX:NXN) Small-Cap Volatility Highlights Importance of Corporate Developments Kalkine
Nexsen (ASX:NXN) Advances Point-of-Care Diagnostics Platform as StrepSure Regulatory Pathway Shapes Future Growth - Kalkine
Nexsen (ASX:NXN) Advances Point-of-Care Diagnostics Platform as StrepSure Regulatory Pathway Shapes Future Growth Kalkine
Launch of Hong Kong facility & pipeline expansion
other announcement
Nexsen (ASX:NXN) Ticks Higher: What's Sparking Interest in This Explorer? - Kalkine
Nexsen (ASX:NXN) Ticks Higher: What's Sparking Interest in This Explorer? Kalkine
Why Did Nexsen (ASX: NXN) Retreat Despite a 40% One-Year Gain? - Kalkine
Why Did Nexsen (ASX: NXN) Retreat Despite a 40% One-Year Gain? Kalkine
Global Healthcare CEO Joins Nexsen Advisory Board
other announcement
Why Nexsen (ASX:NXN) Tumbled Today — Here’s What’s Going On - Kalkine
Why Nexsen (ASX:NXN) Tumbled Today — Here’s What’s Going On Kalkine
Nexsen (ASX:NXN) Shares Surge on Asia-Pacific Expansion Milestone - Kalkine
Nexsen (ASX:NXN) Shares Surge on Asia-Pacific Expansion Milestone Kalkine
KalkineWhy Is (NXN) Cash Strategy Drawing Market Attention?
Highlights Cash runway remains a key focus Rising expenses shaping outlook Funding flexibility offers cushion Nexsen’s financial trajectory highlights a balance between growth spending and cash management, with its runway and funding options shaping investor sentiment. Understanding Nexsen’s Financial Position Within the broader landscape of ASX 100, ASX 200, and ASX 300 companies, emerging businesses often follow a different financial path compared to established players. O...
We're Hopeful That Nexsen (ASX:NXN) Will Use Its Cash Wisely - simplywall.st
We're Hopeful That Nexsen (ASX:NXN) Will Use Its Cash Wisely simplywall.st
HK$6 million grant awarded to advance Asia-Pacific execution
other announcement
FDA feedback derisks US approval pathway for StrepSure
other announcement
Business Update - FDA engagement underway & key appointment
other announcement
Nexsen Appoints Global Clinical Leader to the Board
other announcement
Nexsen launches clinical trial for GBS Rapid Sensor
other announcement